Related references
Note: Only part of the references are listed.Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome
Felipe Correa-da-Silva et al.
JOURNAL OF NEUROENDOCRINOLOGY (2021)
Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome
Nathalie Kayadjanian et al.
PLOS ONE (2021)
Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium
Lauren Schwartz et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2021)
Systematic Review and Meta-analysis: Mental Health in Children With Neurogenetic Disorders Associated With Intellectual
Emma J. Glasson et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2020)
Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update
Merlin G. Butler et al.
CURRENT PEDIATRIC REVIEWS (2019)
THE OXYTOCIN RECEPTOR: FROM INTRACELLULAR SIGNALING TO BEHAVIOR
Benjamin Jurek et al.
PHYSIOLOGICAL REVIEWS (2018)
High levels of caregiver burden in Prader-Willi syndrome
Nathalie Kayadjanian et al.
PLOS ONE (2018)
Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome
Elisabeth M. Dykens et al.
JCI INSIGHT (2018)
Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome
Lisa C. Burnett et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
The Use of Oxytocin to Improve Feeding and Social Skills in Infants With Prader-Willi Syndrome
Maithe Tauber et al.
PEDIATRICS (2017)
Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial
Shawn E. McCandless et al.
DIABETES OBESITY & METABOLISM (2017)
Energy Metabolism Profile in Individuals with Prader-Willi Syndrome and Implications for Clinical Management: A Systematic Review
Maha Alsaif et al.
ADVANCES IN NUTRITION (2017)
Oxytocin treatment in children with Prader-Willi syndrome: A double-blind, placebo-controlled, crossover study
Jennifer L. Miller et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)
Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial
R. J. Kuppens et al.
CLINICAL ENDOCRINOLOGY (2016)
To condition or not condition? Analysing 'change' in longitudinal randomised controlled trials
Cynthia J. Coffman et al.
BMJ OPEN (2016)
An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism
Hamid Meziane et al.
BIOLOGICAL PSYCHIATRY (2015)
A Double-Blind Randomized Controlled Trial of Oxytocin Nasal Spray in Prader Willi Syndrome
Stewart L. Einfeld et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2014)
Prader-Willi syndrome
Suzanne B. Cassidy et al.
GENETICS IN MEDICINE (2012)
The imprinted NPAP1/C15orf2 gene in the PraderWilli syndrome region encodes a nuclear pore complex associated protein
Lisa C. Neumann et al.
HUMAN MOLECULAR GENETICS (2012)
Nutritional Phases in Prader-Willi Syndrome
Jennifer L. Miller et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2011)
Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients
Maithe Tauber et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene
Fabienne Schaller et al.
HUMAN MOLECULAR GENETICS (2010)
Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?
Guanghan F. Liu et al.
STATISTICS IN MEDICINE (2009)
Hochbergs step-up method: Cutting corners off holms step-down method
Yifan Huang et al.
BIOMETRIKA (2007)
Energy expenditure and phvsical activity in Prader-Willi syndrome: Comparison with obese subjects
Merlin G. Butler et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2007)
Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice
IF Bielsky et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Share Paper
